Search BRITE hierarchies

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
  N NERVOUS SYSTEM
    N02 ANALGESICS
      N02C ANTIMIGRAINE PREPARATIONS
        N02CC Selective serotonin (5HT1) agonists [DG:DG01943]
          N02CC04 Rizatriptan [DG:DG00838]
            D00675  Rizatriptan benzoate (JAN/USP) <JP/US>

USP drug classification [BR:br08302]
  Antimigraine Agents
    Serotonin (5-HT) Receptor Agonists
      Rizatriptan [DG:DG00838]
        D00675  Rizatriptan benzoate (JAN/USP)

Therapeutic category of drugs in Japan [BR:br08301]
  2  Agents affecting individual organs
    21  Cardiovascular agents
      216  Vasoconstrictors
        2160  Vasoconstrictors
          D00675  Rizatriptan benzoate (JAN/USP)

Drug groups [BR:br08330]
  Analgesic
    DG01484  5-HT1B-receptor agonist
      DG00838  Rizatriptan
        D00675  Rizatriptan benzoate
    DG01485  5-HT1D-receptor agonist
      DG00838  Rizatriptan
        D00675  Rizatriptan benzoate
    DG01518  5-HT1B/1D-receptor agonist
      DG00838  Rizatriptan
        D00675  Rizatriptan benzoate
    DG01943  Triptan
      DG00838  Rizatriptan
        D00675  Rizatriptan benzoate

Target-based classification of drugs [BR:br08310]
  G Protein-coupled receptors
    Rhodopsin family
      Serotonin
        HTR1B [HSA:3351] [KO:K04153]
          D00675  Rizatriptan benzoate (JAN/USP) <JP/US>
        HTR1D [HSA:3352] [KO:K04153]
          D00675  Rizatriptan benzoate (JAN/USP) <JP/US>

New drug approvals in Japan [br08318.html]
  D00675